866-997-4948(US-Canada Toll Free)

Global Seasonal Influenza Vaccine Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 106 Pages

This report studies the global market size of Seasonal Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Seasonal Influenza Vaccine in these regions.
This research report categorizes the global Seasonal Influenza Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Seasonal Influenza Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Seasonal Influenza Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Seasonal Influenza Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Seasonal Influenza Vaccine include
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

Market Size Split by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
Market Size Split by Application
Children
Adults
Elderly
Pregnancy

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Seasonal Influenza Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Seasonal Influenza Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Seasonal Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Seasonal Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Seasonal Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Seasonal Influenza Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Seasonal Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Seasonal Influenza Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.4.4 Other
1.5 Market by Application
1.5.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.5.4 Elderly
1.5.5 Pregnancy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Seasonal Influenza Vaccine Market Size
2.1.1 Global Seasonal Influenza Vaccine Revenue 2016-2025
2.1.2 Global Seasonal Influenza Vaccine Sales 2016-2025
2.2 Seasonal Influenza Vaccine Growth Rate by Regions
2.2.1 Global Seasonal Influenza Vaccine Sales by Regions
2.2.2 Global Seasonal Influenza Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Seasonal Influenza Vaccine Sales by Manufacturers
3.1.1 Seasonal Influenza Vaccine Sales by Manufacturers
3.1.2 Seasonal Influenza Vaccine Sales Market Share by Manufacturers
3.1.3 Global Seasonal Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Seasonal Influenza Vaccine Revenue by Manufacturers
3.2.1 Seasonal Influenza Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Seasonal Influenza Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Seasonal Influenza Vaccine Price by Manufacturers
3.4 Seasonal Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Influenza Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccine Sales by Type
4.2 Global Seasonal Influenza Vaccine Revenue by Type
4.3 Seasonal Influenza Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Seasonal Influenza Vaccine Breakdown Data by Application

6 North America
6.1 North America Seasonal Influenza Vaccine by Countries
6.1.1 North America Seasonal Influenza Vaccine Sales by Countries
6.1.2 North America Seasonal Influenza Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Seasonal Influenza Vaccine by Type
6.3 North America Seasonal Influenza Vaccine by Application
6.4 North America Seasonal Influenza Vaccine by Company

7 Europe
7.1 Europe Seasonal Influenza Vaccine by Countries
7.1.1 Europe Seasonal Influenza Vaccine Sales by Countries
7.1.2 Europe Seasonal Influenza Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Seasonal Influenza Vaccine by Type
7.3 Europe Seasonal Influenza Vaccine by Application
7.4 Europe Seasonal Influenza Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Seasonal Influenza Vaccine by Countries
8.1.1 Asia Pacific Seasonal Influenza Vaccine Sales by Countries
8.1.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Seasonal Influenza Vaccine by Type
8.3 Asia Pacific Seasonal Influenza Vaccine by Application
8.4 Asia Pacific Seasonal Influenza Vaccine by Company

9 Central & South America
9.1 Central & South America Seasonal Influenza Vaccine by Countries
9.1.1 Central & South America Seasonal Influenza Vaccine Sales by Countries
9.1.2 Central & South America Seasonal Influenza Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Seasonal Influenza Vaccine by Type
9.3 Central & South America Seasonal Influenza Vaccine by Application
9.4 Central & South America Seasonal Influenza Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Seasonal Influenza Vaccine by Countries
10.1.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Countries
10.1.2 Middle East and Africa Seasonal Influenza Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Seasonal Influenza Vaccine by Type
10.3 Middle East and Africa Seasonal Influenza Vaccine by Application
10.4 Middle East and Africa Seasonal Influenza Vaccine by Company

11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.1.4 Seasonal Influenza Vaccine Product Description
11.1.5 Recent Development
11.2 Sinovac
11.2.1 Sinovac Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.2.4 Seasonal Influenza Vaccine Product Description
11.2.5 Recent Development
11.3 Changsheng
11.3.1 Changsheng Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.3.4 Seasonal Influenza Vaccine Product Description
11.3.5 Recent Development
11.4 CCBIO
11.4.1 CCBIO Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.4.4 Seasonal Influenza Vaccine Product Description
11.4.5 Recent Development
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.5.4 Seasonal Influenza Vaccine Product Description
11.5.5 Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.6.4 Seasonal Influenza Vaccine Product Description
11.6.5 Recent Development
11.7 Lanzhou Institute Of Biological Product
11.7.1 Lanzhou Institute Of Biological Product Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.7.4 Seasonal Influenza Vaccine Product Description
11.7.5 Recent Development
11.8 Siobp
11.8.1 Siobp Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.8.4 Seasonal Influenza Vaccine Product Description
11.8.5 Recent Development
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.9.4 Seasonal Influenza Vaccine Product Description
11.9.5 Recent Development
11.10 Tianyuan Bio-Pharma
11.10.1 Tianyuan Bio-Pharma Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Seasonal Influenza Vaccine
11.10.4 Seasonal Influenza Vaccine Product Description
11.10.5 Recent Development
11.11 Vaxtec
11.12 Hissen
11.13 Abbott
11.14 Novartis
11.15 Tasly&Jenner
11.16 Tiantan

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Seasonal Influenza Vaccine Raw Material
13.1.2 Seasonal Influenza Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Seasonal Influenza Vaccine
Figure Global Seasonal Influenza Vaccine Production (K Dose) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Seasonal Influenza Vaccine Production Market Share by Types (Product Category) in 2017
Figure Trivalent Influenza Vaccine Product Picture
Table Major Manufacturers of Trivalent Influenza Vaccine
Figure Quadrivalent Influenza Vaccine Product Picture
Table Major Manufacturers of Quadrivalent Influenza Vaccine
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Seasonal Influenza Vaccine Market Size Growth Rate by Application 2018-2025 (K Dose)
Figure Children
Figure Adults
Figure Elderly
Figure Pregnancy
Figure Seasonal Influenza Vaccine Report Years Considered
Figure Global Seasonal Influenza Vaccine Market Size 2016-2025 (Million US$)
Figure Global Seasonal Influenza Vaccine Sales 2016-2025 (K Dose)
Table Global Seasonal Influenza Vaccine Market Size by Regions 2016-2025 (K Dose) & (Million US$)
Table Global Seasonal Influenza Vaccine Sales by Regions 2016-2025 (K Dose)
Table Global Seasonal Influenza Vaccine Sales Market Share by Regions 2016-2025
Figure Global Seasonal Influenza Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Seasonal Influenza Vaccine Sales Market Share by Regions
Table Global Seasonal Influenza Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Seasonal Influenza Vaccine Revenue Market Share by Regions
Table Global Seasonal Influenza Vaccine Sales by Manufacturers (2016-2018) (K Dose)
Table Global Seasonal Influenza Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Seasonal Influenza Vaccine Sales Share by Manufacturers in 2017
Table Seasonal Influenza Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Seasonal Influenza Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Seasonal Influenza Vaccine Value Share by Manufacturers in 2017
Table Global Seasonal Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Seasonal Influenza Vaccine Price (2016-2018) (USD/Doses)
Table Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Seasonal Influenza Vaccine Product Category
Table Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table Global Seasonal Influenza Vaccine Sales Share by Type (2016-2025)
Figure Global Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure Global Seasonal Influenza Vaccine Sales Market Share by Type in 2017
Table Global Seasonal Influenza Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Share by Type (2016-2025)
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Type in 2017
Table Seasonal Influenza Vaccine Price by Type 2013-2018 (USD/Doses)
Table Global Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table Global Seasonal Influenza Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Seasonal Influenza Vaccine Market Share by Application (2016-2025)
Figure Global Sales Seasonal Influenza Vaccine Market Share by Application (2016-2025)
Figure North America Seasonal Influenza Vaccine Sales Growth Rate 2016-2025 (K Dose)
Figure North America Seasonal Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Seasonal Influenza Vaccine Sales by Countries (2016-2025) (K Dose)
Table North America Seasonal Influenza Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Seasonal Influenza Vaccine Sales Market Share by Countries
Table North America Seasonal Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Seasonal Influenza Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure United States Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure United States Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Canada Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Mexico Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table North America Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Seasonal Influenza Vaccine Market Share by Type
Table North America Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table North America Seasonal Influenza Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Seasonal Influenza Vaccine Market Share by Application
Table North America Seasonal Influenza Vaccine Sales by Company (2016-2018) (K Dose)
Table North America Seasonal Influenza Vaccine Sales Market Share by Company (2016-2018)
Figure North America Seasonal Influenza Vaccine Sales Market Share by Company in 2017
Figure Europe Seasonal Influenza Vaccine Sales Growth Rate 2016-2025 (K Dose)
Figure Europe Seasonal Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Seasonal Influenza Vaccine Sales by Countries (2016-2025) (K Dose)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Seasonal Influenza Vaccine Sales Market Share by Countries
Table Europe Seasonal Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Seasonal Influenza Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure Germany Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Germany Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (K Dose)
Figure France Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure France Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (K Dose)
Figure UK Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure UK Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Italy Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Russia Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Seasonal Influenza Vaccine Market Share by Type
Table Europe Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Seasonal Influenza Vaccine Market Share by Application
Table Europe Seasonal Influenza Vaccine Sales by Company (2016-2018) (K Dose)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Seasonal Influenza Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Seasonal Influenza Vaccine Sales Growth Rate 2016-2025 (K Dose)
Figure Asia Pacific Seasonal Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Sales by Countries (2016-2025) (K Dose)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Countries
Table Asia Pacific Seasonal Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure China Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure China Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Japan Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Korea Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure India Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Australia Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Indonesia Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Malaysia Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Philippines Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Thailand Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Vietnam Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Singapore Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Seasonal Influenza Vaccine Market Share by Type
Table Asia Pacific Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Seasonal Influenza Vaccine Market Share by Application
Table Asia Pacific Seasonal Influenza Vaccine Sales by Company (2016-2018) (K Dose)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Company in 2017
Figure Central & South America Seasonal Influenza Vaccine Sales Growth Rate 2016-2025 (K Dose)
Figure Central & South America Seasonal Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Seasonal Influenza Vaccine Sales by Countries (2016-2025) (K Dose)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Seasonal Influenza Vaccine Sales Market Share by Countries
Table Central & South America Seasonal Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Seasonal Influenza Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure Brazil Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Brazil Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Argentina Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Seasonal Influenza Vaccine Market Share by Type
Table Central & South America Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Seasonal Influenza Vaccine Market Share by Application
Table Central & South America Seasonal Influenza Vaccine Sales by Company (2016-2018) (K Dose)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Seasonal Influenza Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Seasonal Influenza Vaccine Sales Growth Rate 2016-2025 (K Dose)
Figure Middle East and Africa Seasonal Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Countries (2016-2025) (K Dose)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Countries
Table Middle East and Africa Seasonal Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure GCC Countries Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure GCC Countries Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Turkey Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure Egypt Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Seasonal Influenza Vaccine Sales Growth Rate (2016-2025) (K Dose)
Figure South Africa Seasonal Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Type (2016-2025) (K Dose)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Seasonal Influenza Vaccine Market Share by Type
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Application (2016-2025) (K Dose)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Seasonal Influenza Vaccine Market Share by Application
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Company (2016-2018) (K Dose)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Company in 2017
Table GSK Company Details
Table GSK Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Sinovac Company Details
Table Sinovac Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Sinovac Recent Development
Table Changsheng Company Details
Table Changsheng Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Changsheng Recent Development
Table CCBIO Company Details
Table CCBIO Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table CCBIO Recent Development
Table Aleph Biomedical Company Details
Table Aleph Biomedical Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Aleph Biomedical Recent Development
Table Sanofi Company Details
Table Sanofi Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Lanzhou Institute Of Biological Product Company Details
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Lanzhou Institute Of Biological Product Recent Development
Table Siobp Company Details
Table Siobp Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Siobp Recent Development
Table Hualan Bio Company Details
Table Hualan Bio Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Hualan Bio Recent Development
Table Tianyuan Bio-Pharma Company Details
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Tianyuan Bio-Pharma Recent Development
Table Vaxtec Company Details
Table Hissen Company Details
Table Abbott Company Details
Table Novartis Company Details
Table Tasly&Jenner Company Details
Table Tiantan Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Seasonal Influenza Vaccine Value Chain
Table Typical Suppliers of Key Seasonal Influenza Vaccine Raw Material
Table Seasonal Influenza Vaccine Customers List
Table Seasonal Influenza Vaccine Sales Channels
Table Seasonal Influenza Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *